Exercise & FitnessResearch PaperPaywall

Hybrid Prenatal Exercise Program Eliminates Macrosomia Risk in RCT

Pregnant women in a supervised hybrid exercise program had zero cases of macrosomia vs. 7.3% in usual care controls.

Saturday, May 16, 2026 0 views
Published in Med Sci Sports Exerc
A visibly pregnant woman doing a gentle supervised exercise session in a bright hospital gym, with a trainer nearby and a laptop open showing a Zoom class in the background

Summary

A randomized controlled trial found that pregnant women who followed a supervised hybrid exercise program — combining one weekly in-person session with two online Zoom sessions — had zero incidence of macrosomia (birth weight over 4,000g), compared to 7.3% in the usual care group. The program ran from 11 weeks' gestation until delivery and involved moderate-intensity exercise. Babies born to exercising mothers also showed slightly higher 5-minute Apgar scores. While excessive gestational weight gain did not significantly differ between groups, the results suggest that structured prenatal exercise — even when delivered partly online — can meaningfully reduce the risk of oversized newborns and support healthy birth outcomes.

Detailed Summary

Macrosomia — when a newborn exceeds 4,000 grams — is associated with difficult deliveries, birth injuries, and elevated risk of metabolic disease in both mother and child. Finding scalable, low-risk interventions to reduce its incidence is a meaningful clinical priority, especially as gestational weight gain continues to rise globally.

This randomized controlled trial enrolled 260 pregnant women and randomized them equally to an exercise group or a usual care control group. The exercise intervention was delivered in a hybrid format: one supervised in-person session per week at a hospital plus two online sessions per week via Zoom, beginning at 11 weeks' gestation and continuing until delivery. The control group received standard obstetric care, printed lifestyle materials, and a brief phone-based physical activity check-in each trimester. The per-protocol analysis included 138 participants.

The results were striking for macrosomia: zero cases occurred in the exercise group, compared to 7.3% in controls — a statistically significant difference. Five-minute Apgar scores were also modestly but significantly higher in the exercise group (9.91 vs. 9.82). Excessive gestational weight gain trended lower in exercisers (9.6% vs. 19.4%) but did not reach statistical significance, possibly due to limited sample size.

These findings carry practical weight for clinicians and expectant mothers alike. The hybrid delivery model is particularly noteworthy: it demonstrates that the benefits of supervised prenatal exercise can be achieved without requiring full in-person attendance, making the intervention far more accessible for women with transportation barriers or busy schedules.

Caveats include the per-protocol analysis (which excludes dropouts and may overestimate effect sizes), the relatively small final sample, and the fact that this summary is based on the abstract only. Longer-term outcomes for mother and child were not reported.

Key Findings

  • Zero macrosomia cases in the exercise group vs. 7.3% in usual care (p=0.01).
  • Hybrid format (1 in-person + 2 Zoom sessions/week) was feasible throughout pregnancy.
  • 5-minute Apgar scores were slightly but significantly higher in exercising mothers.
  • Excessive gestational weight gain trended lower in exercisers but did not reach significance.
  • Intervention began at 11 weeks and continued until delivery with moderate intensity.

Methodology

This was a randomized controlled trial (NCT04563065) with 1:1 allocation; 138 of 260 enrolled participants were included in the per-protocol analysis. The exercise intervention combined weekly hospital-based sessions with twice-weekly Zoom sessions from 11 weeks' gestation to delivery. Outcomes were extracted from hospital records using standard definitions (macrosomia >4,000g; EGWG per IOM criteria).

Study Limitations

The per-protocol analysis excludes participants who did not adhere to the protocol, which may inflate observed effect sizes compared to intention-to-treat results. The final sample of 138 participants limits statistical power, particularly for the gestational weight gain outcome. This summary is based on the abstract only, as the full text was not available.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.